Home/Filings/4/0001628280-25-026499
4//SEC Filing

Silvestro Stephen L 4

Accession 0001628280-25-026499

CIK 0001448431other

Filed

May 18, 8:00 PM ET

Accepted

May 19, 4:03 PM ET

Size

7.4 KB

Accession

0001628280-25-026499

Insider Transaction Report

Form 4
Period: 2025-05-15
Silvestro Stephen L
Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2025-05-15+46,948168,262 total
  • Award

    Stock Option

    2025-05-15+80,88480,884 total
    Exercise: $10.65From: 2026-05-15Exp: 2029-05-15Common Stock (80,884 underlying)
Footnotes (2)
  • [F1]Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on May 15, 2026, which is the first anniversary of the date of grant.
  • [F2]The stock option vests in three equal annual installments beginning May 15, 2026, the first anniversary of the grant date.

Issuer

OptimizeRx Corp

CIK 0001448431

Entity typeother

Related Parties

1
  • filerCIK 0001773461

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:03 PM ET
Size
7.4 KB